Sanofi (CIK 1121404) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-12). Recent activity: Buy LTGO (494,800 shares), Buy LTGO (177,978 shares), Buy ATTO (782,855 shares), Buy ATTO (300,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Latigo Biotherapeutics, Inc. (LTGO) | 10% Owner | Buy | 494,800 | $0 |
| 2026-08-12 | Latigo Biotherapeutics, Inc. (LTGO) | 10% Owner | Buy | 177,978 | $0 |
| 2026-08-07 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 782,855 | $0 |
| 2026-08-07 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 300,000 | $5.1M |
Source: SEC Form 4 filings · as of 2026-08-12